Mold Toxins Test from Superpower

The panel is $289, separate from the $199 per year membership billed annually. Confirm whether membership applies to your order before paying. Checkout applicability, renewal, shipping, refunds, delivered total, and comparative value remain unassessed.

Exact offer page publishes the measured set: 11 named mycotoxins in table. Eleven named mycotoxins are listed. Associated mold sources and health categories add context and are not extra analytes. The bounded panel does not establish a complete assessment of mold exposure or other causes of illness.

Results delivered to Superpower dashboard with reference ranges/flagged values; Superpower care team (and AI concierge on most pages) available for interpretation; several pages add an updated Action Plan. Results identify which listed toxins are present and report detected concentration in ng/g creatinine. The workflow includes an updated Action Plan and care-team discussion. Validated action thresholds, a complete sample report, and independent clinical utility remain unverified.

Method named: LC-MS/MS at parts-per-trillion sensitivity; lab named: Mosaic Diagnostics, CLIA- and CAP-accredited. The panel names 11 mycotoxins and describes LC-MS/MS measurement of free unconjugated toxins in a CLIA and CAP accredited Mosaic Diagnostics laboratory. This laboratory-developed test does not have FDA clearance or approval. Product-specific precision, reference intervals, analytical validation, and independent performance evidence remain unverified, so this dimension is partial and unscored.

Exact-offer availability list published (40 states, not NY/NJ) plus collection mode (local lab draw / at-home phlebotomist / mail-in kit). Online ordering, an at-home first-morning urine collection, prepaid return materials, and a mailed kit are documented. The service covers 39 states plus Washington, D.C. and excludes New York and New Jersey; address exceptions and shipping destinations beyond that list remain unverified.

Provider privacy and consent materials describe health and laboratory data, partner and laboratory disclosures, contracted processors, de-identified information, and deletion or correction requests. Product-specific retention, specimen disposition, and each laboratory's secondary-use controls remain limited, so privacy is partial and unscored.

The panel measures named mycotoxins for a bounded exposure question. A detected toxin indicates exposure in the sample, not the environmental source or a disease diagnosis, and the clinical benefit of the complete panel for an individual remains unassessed.

The named measurements, first-morning urine specimen, 12-hour fasting recommendation, prepaid return workflow, LC-MS/MS method, creatinine-corrected units, national state list, within-10-day timing, and no New York/New Jersey version are disclosed. This laboratory-developed test does not have FDA clearance or approval.